19 companies join hands at the meeting next week

 19 companies join hands at the meeting next week

At the 51st listing committee review meeting in 2020 held on November 25, the companies that appeared were Guomai culture media Co., Ltd., Zhonglan Environmental Protection Technology Co., Ltd., and Shenzhen chuangyitong Technology Co., Ltd.

In terms of science and technology innovation board, four meetings this week also ended perfectly, and eight companies successfully held the meeting.

Next week, there are also four review meetings, a total of 8 companies will be considered. Among them, Jinguan Electric Co., Ltd. and Guangdong Fuxin Technology Co., Ltd. will take the lead in the 108th review meeting of the municipal Party Committee on the science and technology innovation board in 2020, which will be held on November 23.

On November 25, Hangzhou Honghua Digital Technology Co., Ltd. and Shenzhen dingyang Technology Co., Ltd.

On November 26, the municipal Party Committee on the science and technology innovation board needs to consider the initial launch of Changsha Xingjia Bioengineering Co., Ltd. and Shanghai ruiang Gene Technology Co., Ltd. (hereinafter referred to as ruiang gene).

Finally, on November 27, Beijing Zhongshu Zhihui Technology Co., Ltd. and Beijing Haitian Ruisheng Technology Co., Ltd. will join hands to break through the science and technology innovation board.

Ruiang gene is a life science enterprise with its own brand of molecular diagnostic products. Its main business is R & D, production, sales, scientific research and testing services of in vitro diagnostic products. It mainly provides services for patients with hematologic diseases (leukemia, lymphoma), solid tumors (lung cancer, colorectal cancer, melanoma, etc.) and infectious diseases (hepatitis B, rubella, herpes simplex, etc.) Molecular accurate detection provides the basis for the formulation of individualized treatment schemes such as risk assessment, disease classification, targeted drug selection and efficacy monitoring. At the same time, the company is also vigorously expanding antigen detection reagent products for immunodiagnosis.

On November 26 next week, there will be another five companies standing in the spotlight, including Emma Technology Group Co., Ltd. (hereinafter referred to as Emma Technology), Zhejiang Huasheng Technology Co., Ltd., Shanghai Action Education Technology Co., Ltd., Shanghai Rural Commercial Bank Co., Ltd., and Qingdao Zhenghe Industry Co., Ltd.

Among them, Emma technology was founded in 1999 and entered the electric bicycle industry in 2004. Its main business is the research, production and sales of electric bicycles, electric mopeds and electric motorcycles. As of the end of June 2019, the company has more than 1900 distributors. In the first half of 2019, the operating revenue of Emma technology was 4.455 billion yuan, and the net profit attributable to its parent was 200 million yuan.

According to the information on the website of the CSRC, Emma technology was originally scheduled to attend the meeting on November 28, 2019, but the audit was cancelled because there are still relevant matters to be further verified.

Source: interface news editor: Wang Wenhua_ NF5982